Lupin Limited reports a strong quarter with profit up 37% to ₹1,175.5 crore. CEO Vinita Gupta, MD Nilesh Gupta, and CFO Ramesh Swaminathan discuss $1 billion US sales trajectory, EBITDA margin outlook, Mirabegron settlement clarity, GLP-1 plans including semaglutide launch, biosimilars pipeline, and growth in India formulations. Is Lupin set for sustained earnings momentum?
#etnow #lupin #q3results #lupinshare #q3earnings #pharmasector #businessnews #budget2026withetnow #stockmarket
Subscribe Now To Our Network Channels :-
Social Media Links :-
Follow us on Google News for latest updates
Comments
Want to join the conversation?
Loading comments...